Vial
CRX Peptide Labs
3 public reports
Tirzepatide
Tirzepatide is listed for controlled laboratory research. Public-reference molecular information is presented separately from measured results in 3 published third-party reports.
Read the published research →PUBLIC COAS
3
MOL. WT
4,813.5
FORMAT
Lyophilized
SEQUENCE
39 aa
DATA
Lab report
CATALOG
TR10 / TR20 / TR30
Quantity per vial
PRICE · CAD
$59.99
1
View COAs3 reports
Tested sample
30 mg
Task number
171211
Analysis date
Jun 23, 2026
Measured results
Tirzepatide: 35.58 mg · Purity: 99.845%
Tested sample
15 mg
Task number
171261
Analysis date
Jun 23, 2026
Measured results
Tirzepatide: 17.37 mg · Purity: 99.685%
Tested sample
20 mg
Task number
197315
Analysis date
Jun 30, 2026
Measured results
Tirzepatide: 22.53 mg · Purity: 99.647%
| Tested sample | Task number | Analysis date | Measured results | Report |
|---|---|---|---|---|
| 30 mg | 171211 | Jun 23, 2026 | Tirzepatide: 35.58 mg · Purity: 99.845% | |
| 15 mg | 171261 | Jun 23, 2026 | Tirzepatide: 17.37 mg · Purity: 99.685% | |
| 20 mg | 197315 | Jun 30, 2026 | Tirzepatide: 22.53 mg · Purity: 99.647% |
◆ Lab report available
◆ Shipping shown at checkout
Research overview
Tirzepatide is listed for controlled laboratory research. Public-reference molecular information is presented separately from measured results in 3 published third-party reports.
Published third-party results apply to the named tested samples in each report. Sample strengths and measured values remain report-specific and should not be read as blanket claims for every size or future lot.
Intended use
For laboratory research use only. Not a drug, food, or cosmetic. Not for human or veterinary use, ingestion, or any form of consumption. Sold exclusively to qualified researchers.
What's included
◆One lyophilized vial at the selected quantity
◆Access to the published sample report
◆Order and shipping details shown at checkout
